The upregulation of CPT‐1α expression can facilitate lipid metabolism in adipocytes, hepatocytes, and skeletal muscle cells, thereby mitigating the lipid metabolic disorders associated with T2DM (Dong et al. 2024). Here, CPT1A is linked to Disorder of lipid metabolism.